We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The final model guidelines for Medicare drug formularies represent a practical
compromise that is focused on the needs of patients and practitioners, according
to the head of U.S. Pharmacopeia (USP), which recently released the guidelines.
AstraZeneca Europe's third-biggest drugmaker, cut roughly 500 contract sales
positions, or almost 10 percent of its U.S. sales force, after setbacks with
the Exanta blood-thinner and lung cancer treatment Iressa.
Alnylam Pharmaceuticals, a leading therapeutic RNA interference (RNAi) company,
has granted GeneCare Research Institute, a Japanese biotechnology firm, an exclusive
license through the InterfeRx licensing program to discover, develop and commercialize
RNAi therapeutics directed against two DNA helicase genes associated with cancer.
Savient Pharmaceuticals, an emerging specialty pharmaceutical company engaged
in developing, manufacturing and marketing pharmaceutical products that address
unmet medical needs has announced the exclusive marketing agreement between
their wholly owned subsidiary, Rosemont Pharmaceuticals ("Rosemont")
and O.R.C.A.PHARM GmbH to market and distribute Soltamox (tamoxifen oral liquid
solution) in Germany.
Tripos has completed its acquisition of Optive Research, an Austin, Texas, firm
that develops, markets and supports life science software, the company said.
TaiGen Biotechnology has announced the signing of
a strategic alliance relationship with Procter & Gamble Pharmaceuticals
(P&GP) to further the development and commercialization of a novel non-flourinated
quinolone antibiotic, invented by P&GP.
Following in the footsteps of other drugmakers, GlaxoSmithKline (GSK) is joining
the relief efforts to help the victims of the recent earthquake and tsunami
that have devastated countries in Asia and along the east coast of Africa.